SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ashe Andrew D.

(Last)

(First)

(Middle)

C/O DYAX CORP.

55 NETWORK DRIVE

(Street)

BURLINGTON

01803

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/25/2013

3. Issuer Name and Ticker or Trading Symbol
DYAX CORP [ DYAX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	General Counsel & Sr. VP, Adm.

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	15,000⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	02/11/2013	02/11/2019	Common Stock	15,000	$2.39	D
Stock Option (right to buy)	⁽²⁾	02/10/2021	Common Stock	13,200	$1.87	D
Stock Option (right to buy)	⁽³⁾	01/03/2022	Common Stock	30,000	$1.41	D
Stock Option (right to buy)	⁽⁴⁾	02/24/2022	Common Stock	97,500	$1.48	D
Stock Option (right to buy)	⁽⁵⁾	06/20/2022	Common Stock	70,320	$2.06	D
Stock Option (right to buy)	⁽⁶⁾	02/07/2023	Common Stock	75,000	$3	D

Explanation of Responses:

1. The securities reported were granted pursuant to the Issuer's Amended and Restated 1995 Equity Incentive Plan. The award vests in four (4) equal annual installments beginning on February 24, 2013.

2. Such option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equiavalent is accumulated). The grant date was February 10, 2011.

3. Such option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equiavalent is accumulated). The grant date was January 3, 2012.

4. Such option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equiavalent is accumulated). The grant date was February 24, 2012.

5. Such option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equiavalent is accumulated). The grant date was June 20, 2012.

6. Such option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equiavalent is accumulated). The grant date was February 7, 2013.

Remarks:

	/s/ Nathaniel S. Gardiner as attorney-in-fact	04/01/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.